1. Home
  2. Live Updates
  3. Ity of hope

Live Breaking News & Updates on Ity of hope

Stay informed with the latest breaking news from Ity of hope on our comprehensive webpage. Get up-to-the-minute updates on local events, politics, business, entertainment, and more. Our dedicated team of journalists delivers timely and reliable news, ensuring you're always in the know. Discover firsthand accounts, expert analysis, and exclusive interviews, all in one convenient destination. Don't miss a beat — visit our webpage for real-time breaking news in Ity of hope and stay connected to the pulse of your community

Kaiser Permanente notifies 13.4 million members of data breach. City of Hope also reported breach

User information was inadvertently transmitted to Google, Microsoft Bing and the social media platform formerly known as Twitter, according to Kaiser Permanente.

Oakland , California , United-states , Illinois , Arizona , Los-angeles , Georgia , Kaiser-permanente , Twitter , Los-angeles-times , Google , Microsoft-bing

City of Hope invests $33M in cancer support startup

Discover how City of Hope's $33 million investment in AccessHope is expanding access to leading cancer expertise through partnerships with health systems.

Bradley-kreick , Harlan-levine , Fred-hutch-cancer-center , Dana-farber-cancer-institute , Boston-based-dana-farber-cancer-institute , Atlanta-based-emory-healthcare , Seattle-based-fred-hutch-cancer-center , Baltimore-based-johns-hopkins-medicine , Chicago-based-northwestern , Duarte , Alif , Ity-of-hope

The Critical Nature of Decision-Making in the Development of Phase 3 Clinical Trials

Randomized trials are widely recognized to play a pivotal role in the decision-making associated with the establishment of clinical guidelines.

Abi-jaoude , Oncology-gynecologic-group , Gynecologic-oncology-group , Natl-compr-canc , Ity-of-hope , News , Ncology-business-management ,

Where 11 cancer centers stand financially: Moody

Discover the top cancer centers and hospitals with strong programs, rated in the

Cambridge , Cambridgeshire , United-kingdom , Rochester , New-york , United-states , Memorial-sloan-kettering-cancer-center , Boston , Massachusetts , Dana-farber-cancer-institute , Los-angeles , Sinai-health-system

City of Hope, TGen Researchers Develop Machine-Learning Tool to Detect Cancer Earlier via Liquid Biopsy

The innovative “fragmentomics” approach could one day allow doctors to identify cancer in patients sooner than possible today using smaller blood draws.

United-states , Kamel-lahouel , Cristian-tomasetti , City-of-hope-center , Translational-genomics-research-institute-tgen , Tgen-integrated-cancer-genomics-division , John-hopkins-university , Translational-genomics-research-institute , Science-translational , Cancer-prevention , Alu-profile-learning-using-sequencing , Integrated-cancer-genomics-division

Dr Barzi on the Real-World Use of Triplet Chemotherapies in mCRC

Afsaneh Barzi, MD, PhD, discusses the frontline use of FOLFOXIRI plus bevacizumab and subsequent therapies in patients with metastatic colorectal cancer.

United-states , Afsaneh-barzi , Department-of-medical-oncology , Flatiron-health , Therapeutics-research , Medical-oncology , Ity-of-hope , Onclive-tv , Colorectal-cancer ,

Dr Pal on the Rationale for Investigating Zanzalintinib in Relapsed/Refractory ccRCC

Sumanta Kumar Pal, MD, FASCO, chair, discusses the rationale for treating patients with zanzalintinib in relapsed/refractory clear cell renal cell carcinoma.


Sumanta-kumar-pal , Bladder-cancer-disease-team , Department-of-medical-oncology , Kidney-cancer-program , International-kidney-cancer-symposium , Therapeutics-research , Medical-oncology , Kidney-cancer-symposium , Ity-of-hope , Onclive-tv , Genitourinary-cancers ,

John Sayles on Lone Star and making movies on the border

Director John Sayles, whose neo-Western masterpiece Lone Star arrives on Criterion 4K this week, reveals how the film would be different if he made it today

Mexico , Hollywood , California , United-states , Texas , Twin-peaks , El-paso , Uvalde , Arizona , China , Chinese , Texans

Dr Danilov on Addressing BTK Inhibitor Resistance in Relapsed/Refractory CLL and MCL

Alexey Danilov, MD, PhD, discusses how further research, including the development of NX-2127, may address unmet needs related to disease progression in patients with chronic lymphocytic leukemia or mantle cell lymphoma.


Alexey-danilov , Department-of-hematology-hematopoietic-cell-transplantation , Division-of-leukemia , Toni-stephenson-lymphoma-center , Hematopoietic-cell-transplantation , Ity-of-hope , Mantle-cell-lymphoma , Mcl- , Cll , Chronic-lymphocytic-leukemia , Onclive-tv ,

Health Beat: Beating late-stage cancer with targeted radiotherapy

This year, more than 650,000 people in the United States will receive radiation to try to wipe out cancer. Now, a new radiation therapy is turning cancer against itself.

United-states , Terrence-williams , Radiation-oncologist , Fda , One-disease , Umor , Adioactivity , Adiation-therapy , Ancer , Ity-of-hope , Ung-cancer , Argeted-radiotherapy